Skip to content

Clinical trials

Alzheimer Disease trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Country / region: Spain Clear all

267 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20042
20053
20064
20079
20084
20099
20104
20117
201214
201312
201415
201511
201615
201718
201813
201911
202012
202120
202216
202310
202420
202521
202615

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed127
Terminated56
Recruiting30
Active, not recruiting22
Unknown status17
Not yet recruiting9
Enrolling by invitation5
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche19
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation15
Pfizer12
Eli Lilly and Company9
GlaxoSmithKline8
Washington University School of Medicine8
Janssen Research & Development, LLC7
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau6
Novartis Pharmaceuticals6
AstraZeneca5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease267
Dementia69
Cognitive Dysfunction45
Neurodegenerative Diseases19
Brain Diseases17
Mental Disorders14
Central Nervous System Diseases13
Nervous System Diseases13
Neurocognitive Disorders9
Tauopathies9

Trials

Showing 26 to 50 of 267. Each trial links to its page on Pharma Observatory.

167 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.